Drug Trial Radar · NCT07867171
A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 23, 2026
Primary completion
Sep 9, 2027
Study completion Sep 9, 2027
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study evaluates the effect of moderate and severe renal impairment on the pharmacokinetics (PK) of velzatinib compared with normal renal function.
Conditions
- Healthy Participants
- Gastrointestinal Neoplasms
Interventions
VelzatinibDrug
Velzatinib will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum observed plasma concentration (Cmax)Time frame: Up to 936 hours
- Area under the concentration-time curve from time zero extrapolated to infinity (AUC[0-inf])Time frame: Up to 936 hours
- Maximum plasma unbound concentration (Cmax,u)Time frame: Up to 936 hours
- Area under the unbound plasma concentration-time curve extrapolated to infinity (AUC[0-inf],u)Time frame: Up to 936 hours
- Renal clearance (CLr)Time frame: Up to Day 3
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.